We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Perrigo Selling Generic Drug Business for $1.55 Billion
Perrigo Selling Generic Drug Business for $1.55 Billion
Over-the-counter drug major Perrigo said this week it is selling its generic prescription drug business to Altaris Capital Partners for $1.55 billion. The purchaser is paying $1.5 billion in cash and taking on more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party prescription partners.